PicoWay receives CE mark for tattoo removal and pigmented lesions

Syneron Candela’s new device, PicoWay®, has received CE Mark indication to treat tattoos of all types and colours and pigmented lesions on any skin type. PicoWay is a dual wave length device, with 532nm and 1064nm wave lengths, which utilises Syneron's proprietary PicoWay technology to deliver energy to the skin using pulses which are trillionths of a second, known as picosecond pulses. The company will begin a staged launch of the PicoWay device in the international market during the third quarter of 2014 and anticipates that it will receive US Food and Drug Administration (FDA) clearance for PicoWay by the end of 2014. The UK launch will be at the CCR Expo on October 10-11. PicoWay's high peak power and ultra-short pulse duration enable a unique mode of action which creates the strongest photo-mechanical impact to break up the tattoo ink or the pigmentation. "Our investment in PicoWay's research and development demonstrate Syneron's commitment to develop technology that enables physicians to provide best-in-practice treatments for their patients," stated AmitMeridor, CEO of Syneron. "Since PicoWay has the shortest picosecond pulse duration and the highest peak power of any device on the market, we believe that fewer treatments will be needed and that the percentage clearance will be higher.”